Metraipolis › archive › dc_57775177db39

Controlled-Release Nanoparticles for the Treatment of Childhood Refractory Epilepsy in Latin America — Europe PMC PMID:42927454

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42927454
DOI
10.1155/bmri/3576367
License (as archived)
solo-consultazione
Archived
2026-11-07T04:46:24.171Z
SHA-256 of the archived text
3886cf8bd2b3cccd729a2bbc19f76219d1d367efe48c4581f2b9b1a208da8baa
Stable URL of this page
https://metraipolis.com/documento/dc_57775177db39

How to cite

Controlled-Release Nanoparticles for the Treatment of Childhood Refractory Epilepsy in Latin America — Europe PMC PMID:42927454 — Europe PMC (en), https://europepmc.org/article/MED/42927454 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57775177db39 (Metraipolis archive dc_57775177db39, sha256 3886cf8bd2b3cccd729a2bbc19f76219d1d367efe48c4581f2b9b1a208da8baa)
BibTeX
@misc{dc57775177db39,
  title = {Controlled-Release Nanoparticles for the Treatment of Childhood Refractory Epilepsy in Latin America — Europe PMC PMID:42927454},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42927454},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57775177db39; sha256 3886cf8bd2b3cccd729a2bbc19f76219d1d367efe48c4581f2b9b1a208da8baa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42927454. Agents can read the archived copy with the MCP tool read_document.